# Acne Inversa (Hidradenitis Suppurativa) in the Early Stage

Canonical URL: https://www.acneinversa.life/en/blog/early-stage-hidradenitis-suppurativa/
Markdown URL: https://www.acneinversa.life/en/blog/early-stage-hidradenitis-suppurativa.md
Plain text URL: https://www.acneinversa.life/en/blog/early-stage-hidradenitis-suppurativa.txt
Language: en
Category: Diagnosis
Published: 2026-05-21
Last updated: 2026-05-22
Last editorially reviewed: 2026-05-22
Next scheduled review: 2027-05-22

Author: Dr. rer. nat. Dennis Alexander Kwiatkowski (Biochemist, Scientific Writer and Pharma Expert)
Scientific editor: Dr. rer. nat. Dennis Alexander Kwiatkowski
Reviewer qualifications: Biochemist, Scientific Writer and Pharma Expert
Review scope: Scientific literature, clinical guidelines, sources, and editorial clarity
Clinical reviewer: No independent clinical review
Tags: Acne Inversa, Hidradenitis Suppurativa, HS, Diagnosis, early stage, acne inversa, hidradenitis suppurativa, diagnosis

> In the early stage, Acne Inversa can seem inconspicuous or unpredictable. Here you'll learn which early changes matter and why an early assessment still counts.

Medical disclaimer: This website is for general educational information only and does not replace medical advice, diagnosis, or treatment. Please speak with qualified medical professionals about symptoms or treatment decisions.

## Article

## What "early stage" means for Acne Inversa

When people search for Acne Inversa in the early stage, they often mean a very practical question: "Could this already be HS, even though I don't yet see pronounced scars or tunnels?"

The honest answer is: early HS can still seem limited. Typical signs may include single or multiple recurring painful nodules or abscesses, without clearly visible tunnels having formed yet. Nonetheless, the classification belongs in professional hands.

"Early stage" is not a substitute for a clinical
severity classification. Doctors can, for example, use the
Hurley system to describe whether tunnels and scarring are present. Anyone who does not yet
have a diagnosis does not need to anticipate this classification themselves. A
general overview is provided in the article [What is Acne Inversa?](/en/blog/what-is-acne-inversa/).

## Quick overview

- Early symptoms can settle down between flares.
- Recurrence in typical regions matters more than a single acute day.
- Scars, discharge, or recurring openings should be included early in the
  description.
- Early assessment is different from alarmism.

## Why early disease is hard to recognize

In the early stage, a flare can heal and things can quiet down in between. As a result, each new nodule can seem like a new isolated problem. Common mix-ups include boils, folliculitis, ingrown hairs, or inflamed cysts. To learn more about how to distinguish such patterns, see [Acne Inversa: Recognizing Early Symptoms](/en/blog/hidradenitis-suppurativa-recognizing-early-symptoms/).

The question is therefore not just: "What does the spot look like today?" But also:

- Is the region typical for HS?
- Does the problem come back?
- Is the spot deep and painful?
- Do scars, open points, or hardened areas remain afterward?

## Which early observations make the appointment more useful

Early symptoms become easier to understand when they are not just described as
"a pimple." A small overview can be enough:

| Observation | Example |
| --- | --- |
| Location | Armpit, groin fold, buttocks, genital area, or under the breast |
| Time pattern | first episode, recurrence, or persistent spot |
| Change | opening up, oozing, subsiding, or scarring |
| Impact | walking, sitting, raising arms, sleep, or clothing |

This information also helps if a flare is less visible at the
appointment than it was at home.

## Early HS is not a waiting room for severe HS

It's understandable to want to wait for clear-cut signs. Medically, however, it usually makes more sense to document and mention recurring symptoms early. This creates a foundation for diagnosis, monitoring the course of the condition, and appropriate questions about care.

An early assessment doesn't mean every spot is dramatized. It means that a recurring pattern is not downplayed.

## What is helpful for the appointment

Bring a brief summary with you:

1. affected body regions,
2. approximate frequency and duration of episodes,
3. photos of active spots, if available,
4. notes on scars, discharge, or recurring openings,
5. the effect on daily life, movement, and sleep.

This turns the word "early stage" into a concrete medical history. Helpful preparation is offered by [15 Questions You Should Ask Your Dermatologist](/en/blog/15-questions-to-ask-your-dermatologist/).

## What early classification does not promise

An early classification does not predict what the individual course will be.
Nor is it meant to guide self-treatment. It creates the basis for
discussing recurring inflammation, pain, and possible structural
changes together with qualified medical professionals.

## When you should seek help sooner

Rapidly increasing redness, fever, sharply increasing pain, or a wound that is clearly worsening should be medically evaluated promptly. For recurring but non-acute symptoms, a scheduled dermatology appointment is the right next step.

## FAQ

### Is early stage the same as Hurley Stage I?

Not automatically. 'Early stage' is often a colloquial search term. Hurley Stage I is a clinical classification without tunnels and pronounced scarring, which is assessed by a doctor.

### Can Acne Inversa subside early on and come back later?

Individual early lesions can subside. What matters for classification is whether painful lesions recur in typical regions or leave behind changes such as scars.

### Why should I document early symptoms?

A brief progress note on body location, recurrence, pain, discharge, and impact on daily life makes the clinical pattern easier to understand during the appointment.

## References

1. S2k Guideline on the Treatment of Hidradenitis Suppurativa / Acne Inversa - AWMF, 2024 - https://register.awmf.org/assets/guidelines/013-012l_S2k_Therapie-Hidradenitis-suppurativa-Acne-inversa_2024-08.pdf
2. Hidradenitis Suppurativa - U.S. Food and Drug Administration, 2024 - https://www.fda.gov/consumers/health-education-resources/hidradenitis-suppurativa
3. North American clinical management guidelines for hidradenitis suppurativa, Part I - Journal of the American Academy of Dermatology, 2019 - https://pubmed.ncbi.nlm.nih.gov/30872156/